BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo X, Guo R, Luo X, Zhou L. Ethyl pyruvate ameliorates experimental colitis in mice by inhibiting the HMGB1-Th17 and Th1/Tc1 responses. International Immunopharmacology 2015;29:454-61. [DOI: 10.1016/j.intimp.2015.10.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhao J, Sun T, Wu S, Liu Y. High Mobility Group Box 1: An Immune-regulatory Protein. CGT 2019;19:100-9. [DOI: 10.2174/1566523219666190621111604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Yang R, Zhu S, Tonnessen TI. Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuries. J Inflamm (Lond) 2016;13:37. [PMID: 27980458 DOI: 10.1186/s12950-016-0144-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
3 Chen W, Lian J, Ye JJ, Mo QF, Qin J, Hong GL, Chen LW, Zhi SC, Zhao GJ, Lu ZQ. Ethyl pyruvate reverses development of Pseudomonas aeruginosa pneumonia during sepsis-induced immunosuppression. Int Immunopharmacol 2017;52:61-9. [PMID: 28863323 DOI: 10.1016/j.intimp.2017.08.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
4 Gajić D, Despotović S, Koprivica I, Miljković Đ, Saksida T. Ethyl Pyruvate Ameliorates Experimental Autoimmune Myocarditis. Biomolecules 2021;11:1768. [PMID: 34944410 DOI: 10.3390/biom11121768] [Reference Citation Analysis]
5 Chen L, Li J, Ye Z, Sun B, Wang L, Chen Y, Han J, Yu M, Wang Y, Zhou Q, Seidler U, Tian D, Xiao F. Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice. Front Immunol 2020;11:585094. [PMID: 33193406 DOI: 10.3389/fimmu.2020.585094] [Reference Citation Analysis]
6 Koprivica I, Vujičić M, Gajić D, Saksida T, Stojanović I. Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice. Front Immunol 2018;9:3130. [PMID: 30687329 DOI: 10.3389/fimmu.2018.03130] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wu L, Yang L. The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications. Oncol Lett 2018;15:6799-805. [PMID: 29725415 DOI: 10.3892/ol.2018.8215] [Cited by in Crossref: 8] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vijayakumar EC, Bhatt LK, Prabhavalkar KS. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics. Curr Drug Targets 2019;20:1474-85. [PMID: 31215389 DOI: 10.2174/1389450120666190618125100] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
9 Koprivica I, Djedovic N, Stojanović I, Miljković Đ. Ethyl pyruvate, a versatile protector in inflammation and autoimmunity. Inflamm Res 2022. [PMID: 34999919 DOI: 10.1007/s00011-021-01529-z] [Reference Citation Analysis]